Cardinal Capital Management Inc (Canada)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-400
Closed -$13K 75
2020
Q2
$13K Sell
400
-500
-56% -$16K ﹤0.01% 66
2020
Q1
$27K Hold
900
﹤0.01% 61
2019
Q4
$26K Hold
900
﹤0.01% 60
2019
Q3
$23K Hold
900
﹤0.01% 53
2019
Q2
$23K Hold
900
﹤0.01% 42
2019
Q1
$24K Hold
900
﹤0.01% 45
2018
Q4
$21K Hold
900
﹤0.01% 45
2018
Q3
$21K Hold
900
﹤0.01% 58
2018
Q2
$21K Hold
900
﹤0.01% 62
2018
Q1
$22K Hold
900
﹤0.01% 61
2017
Q4
$24K Hold
900
﹤0.01% 66
2017
Q3
$22K Hold
900
﹤0.01% 59
2017
Q2
$19K Buy
+900
New +$18.2K ﹤0.01% 60

Other funds holding NVO

Cardinal Capital Management Inc (Canada)'s NVO Position: Q3 2020 in Review

Cardinal Capital Management Inc (Canada) sold out of Novo Nordisk (NVO) in Q3 2020, closing a stake of 400 shares — an estimated $13K sold.

Cardinal Capital Management Inc (Canada) first reported a position in NVO in Q2 2017 and held it in 13 quarters. The position peaked at $27K in Q1 2020. 659 funds tracked by Wall St. Rank hold NVO as of Q3 2020.

  • Cardinal Capital Management Inc (Canada) reported no remaining Novo Nordisk position as of Q3 2020 after selling out during the quarter.
  • Cardinal Capital Management Inc (Canada) sold 400 Novo Nordisk shares in Q3 2020, an estimated $13K.
  • Cardinal Capital Management Inc (Canada) first reported a position in Novo Nordisk in Q2 2017 and held it in 13 quarters.
  • Cardinal Capital Management Inc (Canada)'s Novo Nordisk position peaked at $27K in Q1 2020.
  • 659 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2020.

Based on Cardinal Capital Management Inc (Canada)'s 13F filing for Q3 2020, filed 13 Oct 2020.